Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Wnt5a is a TLR2/4-ligand that induces tolerance in human myeloid cells.

Mehmeti M, Bergenfelz C, Källberg E, Millrud CR, Björk P, Ivars F, Johansson-Lindbom B, Kjellström S, André I, Leandersson K.

Commun Biol. 2019 May 9;2:176. doi: 10.1038/s42003-019-0432-4. eCollection 2019.

2.

The immunomodulatory quinoline-3-carboxamide paquinimod reverses established fibrosis in a novel mouse model for liver fibrosis.

Fransén Pettersson N, Deronic A, Nilsson J, Hannibal TD, Hansen L, Schmidt-Christensen A, Ivars F, Holmberg D.

PLoS One. 2018 Sep 5;13(9):e0203228. doi: 10.1371/journal.pone.0203228. eCollection 2018.

3.

Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse.

Tahvili S, Törngren M, Holmberg D, Leanderson T, Ivars F.

PLoS One. 2018 May 9;13(5):e0196598. doi: 10.1371/journal.pone.0196598. eCollection 2018.

4.

Induction of S100A9 homodimer formation in vivo.

Källberg E, Tahvili S, Ivars F, Leanderson T.

Biochem Biophys Res Commun. 2018 Jun 7;500(3):564-568. doi: 10.1016/j.bbrc.2018.04.086. Epub 2018 Apr 23.

PMID:
29679568
5.
6.

A New Mouse Model That Spontaneously Develops Chronic Liver Inflammation and Fibrosis.

Fransén-Pettersson N, Duarte N, Nilsson J, Lundholm M, Mayans S, Larefalk Å, Hannibal TD, Hansen L, Schmidt-Christensen A, Ivars F, Cardell S, Palmqvist R, Rozell B, Holmberg D.

PLoS One. 2016 Jul 21;11(7):e0159850. doi: 10.1371/journal.pone.0159850. eCollection 2016.

7.

Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus.

Tydén H, Lood C, Gullstrand B, Jönsen A, Ivars F, Leanderson T, Bengtsson AA.

Lupus. 2017 Feb;26(2):139-149. doi: 10.1177/0961203316655208. Epub 2016 Jul 19.

PMID:
27407135
8.
9.

CD14 Is a Co-Receptor for TLR4 in the S100A9-Induced Pro-Inflammatory Response in Monocytes.

He Z, Riva M, Björk P, Swärd K, Mörgelin M, Leanderson T, Ivars F.

PLoS One. 2016 May 26;11(5):e0156377. doi: 10.1371/journal.pone.0156377. eCollection 2016.

10.

Platelet-Derived S100A8/A9 and Cardiovascular Disease in Systemic Lupus Erythematosus.

Lood C, Tydén H, Gullstrand B, Jönsen A, Källberg E, Mörgelin M, Kahn R, Gunnarsson I, Leanderson T, Ivars F, Svenungsson E, Bengtsson AA.

Arthritis Rheumatol. 2016 Aug;68(8):1970-80. doi: 10.1002/art.39656.

11.

Vesicular Location and Transport of S100A8 and S100A9 Proteins in Monocytoid Cells.

Chakraborty P, Bjork P, Källberg E, Olsson A, Riva M, Mörgelin M, Liberg D, Ivars F, Leanderson T.

PLoS One. 2015 Dec 14;10(12):e0145217. doi: 10.1371/journal.pone.0145217. eCollection 2015.

12.

S100A9 as a Pharmacological Target Molecule in Inflammation and Cancer.

Leanderson T, Liberg D, Ivars F.

Endocr Metab Immune Disord Drug Targets. 2015;15(2):97-104. Review.

PMID:
25772177
13.

Quinoline-3-carboxamides modulate primary T cell-dependent B cell responses but do not inhibit functional immunity.

Källberg E, Ivars F, Leanderson T.

Scand J Immunol. 2014 Apr;79(4):237-43. doi: 10.1111/sji.12152.

14.

The quinoline-3-carboxamide paquinimod (ABR-215757) reduces leukocyte recruitment during sterile inflammation: leukocyte- and context-specific effects.

Deronic A, Helmersson S, Leanderson T, Ivars F.

Int Immunopharmacol. 2014 Feb;18(2):290-7. doi: 10.1016/j.intimp.2013.12.008. Epub 2013 Dec 23.

PMID:
24370393
15.

Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.

Tydén H, Lood C, Gullstrand B, Jönsen A, Nived O, Sturfelt G, Truedsson L, Ivars F, Leanderson T, Bengtsson AA.

Rheumatology (Oxford). 2013 Nov;52(11):2048-55. doi: 10.1093/rheumatology/ket263. Epub 2013 Aug 13.

PMID:
23942785
16.

Common interactions between S100A4 and S100A9 defined by a novel chemical probe.

Björk P, Källberg E, Wellmar U, Riva M, Olsson A, He Z, Törngren M, Liberg D, Ivars F, Leanderson T.

PLoS One. 2013 May 8;8(5):e63012. doi: 10.1371/journal.pone.0063012. Print 2013.

17.

Human S100A9 protein is stabilized by inflammatory stimuli via the formation of proteolytically-resistant homodimers.

Riva M, He Z, Källberg E, Ivars F, Leanderson T.

PLoS One. 2013 Apr 23;8(4):e61832. doi: 10.1371/journal.pone.0061832. Print 2013.

18.

Amelioration of experimental autoimmune encephalomyelitis by the quinoline-3-carboxamide paquinimod: reduced priming of proinflammatory effector CD4(+) T cells.

Helmersson S, Sundstedt A, Deronic A, Leanderson T, Ivars F.

Am J Pathol. 2013 May;182(5):1671-80. doi: 10.1016/j.ajpath.2013.01.032. Epub 2013 Mar 16.

PMID:
23506849
19.

S100A9 and tumor growth.

Leanderson T, Ivars F.

Oncoimmunology. 2012 Nov 1;1(8):1404-1405.

20.

CD11b+Ly6C++Ly6G- cells show distinct function in mice with chronic inflammation or tumor burden.

Källberg E, Stenström M, Liberg D, Ivars F, Leanderson T.

BMC Immunol. 2012 Dec 12;13:69. doi: 10.1186/1471-2172-13-69.

21.

Induction of nuclear factor-κB responses by the S100A9 protein is Toll-like receptor-4-dependent.

Riva M, Källberg E, Björk P, Hancz D, Vogl T, Roth J, Ivars F, Leanderson T.

Immunology. 2012 Oct;137(2):172-82. doi: 10.1111/j.1365-2567.2012.03619.x.

22.

S100A9 interaction with TLR4 promotes tumor growth.

Källberg E, Vogl T, Liberg D, Olsson A, Björk P, Wikström P, Bergh A, Roth J, Ivars F, Leanderson T.

PLoS One. 2012;7(3):e34207. doi: 10.1371/journal.pone.0034207. Epub 2012 Mar 28.

23.

Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus.

Lood C, Stenström M, Tydén H, Gullstrand B, Källberg E, Leanderson T, Truedsson L, Sturfelt G, Ivars F, Bengtsson AA.

Arthritis Res Ther. 2011 Apr 14;13(2):R60. doi: 10.1186/ar3314.

24.

Specific effect of immunomodulatory quinoline-3-carboxamide ABR-215757 in GM-CSF stimulated bone marrow cell cultures: block of initiation of proliferation of Gr-1+ cells.

Helmersson S, Stenström M, Leanderson T, Ivars F.

Int Immunopharmacol. 2011 Aug;11(8):1045-51. doi: 10.1016/j.intimp.2011.02.025. Epub 2011 Mar 6.

PMID:
21388612
25.

Indoleamine 2,3-dioxygenase (IDO) activity influence tumor growth in the TRAMP prostate cancer model.

Källberg E, Wikström P, Bergh A, Ivars F, Leanderson T.

Prostate. 2010 Sep 15;70(13):1461-70. doi: 10.1002/pros.21181.

PMID:
20687219
26.

Selective depletion of splenic CD4 dendritic cells in mice treated with immunomodulatory quinoline-3-carboxamide ABR-215757.

Stenström M, Anderson P, Eroukhmanoff L, Leanderson T, Ivars F.

Int Immunopharmacol. 2010 Aug;10(8):837-42. doi: 10.1016/j.intimp.2010.04.011. Epub 2010 Apr 25.

PMID:
20423734
27.

Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides.

Björk P, Björk A, Vogl T, Stenström M, Liberg D, Olsson A, Roth J, Ivars F, Leanderson T.

PLoS Biol. 2009 Apr 28;7(4):e97. doi: 10.1371/journal.pbio.1000097.

28.

Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain.

Wu C, Ivars F, Anderson P, Hallmann R, Vestweber D, Nilsson P, Robenek H, Tryggvason K, Song J, Korpos E, Loser K, Beissert S, Georges-Labouesse E, Sorokin LM.

Nat Med. 2009 May;15(5):519-27. doi: 10.1038/nm.1957. Epub 2009 Apr 26.

PMID:
19396173
29.

T-cell tolerance induced by repeated antigen stimulation: selective loss of Foxp3- conventional CD4 T cells and induction of CD4 T-cell anergy.

Eroukhmanoff L, Oderup C, Ivars F.

Eur J Immunol. 2009 Apr;39(4):1078-87. doi: 10.1002/eji.200838653. Erratum in: Eur J Immunol. 2009 Jun;39(6):1682.

30.

Superantigen-induced regulatory T cells in vivo.

Ivars F.

Chem Immunol Allergy. 2007;93:137-60. Review.

PMID:
17369704
31.

Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft cD4(+)Foxp3(+) T cells.

Oderup C, Malm H, Ekberg H, Qi Z, Veress B, Ivars F, Corbascio M.

Transplantation. 2006 Dec 15;82(11):1493-500.

PMID:
17164722
34.

Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis.

Agrawal S, Anderson P, Durbeej M, van Rooijen N, Ivars F, Opdenakker G, Sorokin LM.

J Exp Med. 2006 Apr 17;203(4):1007-19. Epub 2006 Apr 3.

35.

Quinic acid is a biologically active component of the Uncaria tomentosa extract C-Med 100.

Akesson C, Lindgren H, Pero RW, Leanderson T, Ivars F.

Int Immunopharmacol. 2005 Jan;5(1):219-29.

PMID:
15589483
36.

Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.

Rosendahl A, Speletas M, Leandersson K, Ivars F, Sideras P.

Int Immunol. 2003 Dec;15(12):1401-14.

PMID:
14645149
37.

An extract of Uncaria tomentosa inhibiting cell division and NF-kappa B activity without inducing cell death.

Akesson C, Lindgren H, Pero RW, Leanderson T, Ivars F.

Int Immunopharmacol. 2003 Dec;3(13-14):1889-900.

PMID:
14636838
38.
39.

C-Med 100, a hot water extract of Uncaria tomentosa, prolongs lymphocyte survival in vivo.

Akesson Ch, Pero RW, Ivars F.

Phytomedicine. 2003 Jan;10(1):23-33.

PMID:
12622460
40.

A pTalpha-negative subpopulation of CD25+ TN thymocytes revealed by a transgenic marker.

Petersson K, Mårtensson A, Mertsching E, Winkler T, Ceredig R, Mårtensson IL, Ivars F.

Scand J Immunol. 2002 Feb;55(2):119-28.

41.

The pT alpha promoter and enhancer are direct targets for transactivation by E box-binding proteins.

Petersson K, Ivars F, Sigvardsson M.

Eur J Immunol. 2002 Mar;32(3):911-20.

44.
45.

Characterization of subpopulations of T-cell receptor intermediate (TCRint) T cells.

Sköld M, Rytter A, Ivars F, Cardell S.

Scand J Immunol. 1999 Jun;49(6):611-9.

46.
47.

Naturally activated CD4+ T cells are highly enriched for cytokine-producing cells.

Cederbom L, Bandeira A, Coutinho A, Ivars F.

Eur J Immunol. 1998 Jun;28(6):1934-40.

48.

A TCR alpha chain transgene induces maturation of CD4- CD8- alpha beta+ T cells from gamma delta T cell precursors.

Fritsch M, Andersson A, Petersson K, Ivars F.

Eur J Immunol. 1998 Mar;28(3):828-37.

49.
50.

Signal transduction through the T cell receptor-CD3 complex. Evidence for heterogeneity in receptor coupling.

Brattsand G, Cantrell DA, Ward S, Ivars F, Gullberg M.

J Immunol. 1990 May 15;144(10):3651-8.

PMID:
1970588

Supplemental Content

Support Center